ArticleMedical science monitor : international medical journal of experimental and clinical research2019

The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.

Wen-Hao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.